Optimal timing of antiviral therapy for patients with malignant tumor who presented with hepatitis B reactivation during chemotherapy and/or immunosuppressive therapy

Background: Hepatitis B virus (HBV) reactivation may occur with chemotherapy and/or immunotherapy. Antiviral prophylaxis is recommended for all patients who are hepatitis B surface antigen (HBsAg)-positive during chemotherapy and/or immunosuppressive therapy. However, the optimal timing of antiviral...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Xiaofang, Guo, Longhua, Gu, Yinfang, Yang, Zhijun, Huang, Ping, Liu, Tianhuang, Zhao, Jingjing, Wu, Guowu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150462/
https://www.ncbi.nlm.nih.gov/pubmed/32284752
http://dx.doi.org/10.7150/jca.40154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150462/
https://www.ncbi.nlm.nih.gov/pubmed/32284752
http://dx.doi.org/10.7150/jca.40154

Ejemplares similares